Mandating a Boost to Pfizer’s Bottom Line

The COVID vaccines have been great for drug companies’ bottom lines. Today Pfizer said it sold $7.8 billion worth of shots in the second quarter… with a total of $33.5 billion in sales expected by year-end. The company also stressed once again that everyone might need a third dose of its product to stave off the delta variant. Needless to say, mandating a third jab would boost Pfizer’s profits even higher… which makes it easy to question the drugmaker’s motives. Ray Blanco admits it’s a concern. At the same time, he says, “there’s a lot of misinformation” about exactly how the vaccines really work.